Therefore, based on the currently available evidence and ACMG guidelines, we tend to classify CHCHD10 p.Gly66Val as a pathogenic variant in ALS for the following reasons: (1) Well-established in vitro functional studies have demonstrated a damaging effect of this variant on the gene product, as discussed above (PS3). Here, CHCHD10 is linked to amyotrophic lateral sclerosis.